Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma

New England Journal of Medicine

Volumn 365, Issue 13, 2011, Pages 1173-1183

  Tantisira, Kelan G ^a   Lasky Su, Jessica ^a   Harada, Michishige ^c   Murphy, Amy ^a   Litonjua, Augusto A ^a   Himes, Blanca E ^a   Lange, Christoph ^b   Lazarus, Ross ^a   Sylvia, Jody ^a   Klanderman, Barbara ^a   Duan, Qing Ling ^a   Qiu, Weiliang ^a   Hirota, Tomomitsu ^c   Martinez, Fernando D ⁱ   Mauger, David ^j   Sorkness, Christine ^f   Szefler, Stanley ^k   Lazarus, Stephen C ^d   Lemanske Jr , Robert F ^e   Peters, Stephen P ^g   Lima, John J ^h   Nakamura, Yusuke ^c   Tamari, Mayumi ^c   Weiss, Scott T ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h NEMOURS CHILDREN S CLINIC   (United States)

ⁱ UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^j PENN STATE COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; GLUCOCORTICOID; NEDOCROMIL SODIUM; SALMETEROL; TRIAMCINOLONE;

ARTICLE; ASTHMA; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; ENZYME ACTIVITY; FORCED EXPIRATORY VOLUME; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GLCCI1 GENE; HOMOZYGOSITY; HUMAN; LUNG FUNCTION; MUTANT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE; VALIDATION PROCESS; WILD TYPE;

EID: 80053370268     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0911353     Document Type: Article

References (39)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-78. (Pubitemid 38580764)
2. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000;56:1054-70. (Pubitemid 32417168)
3. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8. (Pubitemid 34234189)
4. Inglis GC, Ingram MC, Holloway CD, et al. Familial pattern of corticosteroids and their metabolism in adult human subjects - the Scottish Adult Twin Study. J Clin Endocrinol Metab 1999;84:4132-7. (Pubitemid 30644205)
5. Ober C, Abney M, McPeek MS. The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001;69:1068-79. [Erratum, Am J Hum Genet 2002;70:284.] (Pubitemid 33015822)
6. Steptoe A, van Jaarsveld CH, Semmler C, Plomin R, Wardle J. Heritability of day-time cortisol levels and cortisol reactivity in children. Psychoneuroendocrinology 2009;34:273-80.
7. Armaly MF. The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 1966;75:32-5.
8. Schwartz JT, Reuling FH, Feinleib M, Garrison RJ, Collie DJ. Twin heritability study of the effect of corticosteroids on intraocular pressure. J Med Genet 1972;9:137-43.
9. Drazen JM, Yandava CN, Dubé L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999;22:168-70. (Pubitemid 29264811)
10. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-12. (Pubitemid 39410416)
11. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004;13:1353-9. (Pubitemid 38961642)
12. Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A 2004;101:18099-104. (Pubitemid 40054080)
13. Tantisira KG, Silverman ES, Mariani TJ, et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 2007;120:1285-91. (Pubitemid 350216603)
14. van Steen K, McQueen MB, Herbert A, et al. Genomic screening and replication using the same data set in family-based association testing. Nat Genet 2005;37:683-91. (Pubitemid 41754884)
15. Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity. Science 2006;312:279-83.
16. Lasky-Su J, Lyon HN, Emilsson V, et al. On the replication of genetic associations: timing can be everything! Am J Hum Genet 2008;82:849-58.
17. Bertram L, Lange C, Mullin K, et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 2008;83:623-32.
18. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. Using the noninformative families in family-based association tests: a powerful new testing strategy. Am J Hum Genet 2003;73:801-11. (Pubitemid 37271884)
19. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 1999;20:91-120.
20. Idem. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000;343:1054-63.
21. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial. JAMA 2001;285:2583-93. (Pubitemid 32479898)
22. Lemanske RF Jr, Sorkness CA, Mauger EA, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial. JAMA 2001;285:2594-603. (Pubitemid 32479899)
23. Bielory L, Picone F, Rabinowitz P, et al. Multicentre, randomised, parallel-group study of the efficacy and tolerability of flunisolide administered once daily via AeroChamber in the treatment of mild to moderate asthma. Clin Drug Investig 2000;19:93-101. (Pubitemid 30139293)
24. Peters SP, Anthonisen N, Castro M, et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-39. [Erratum, N Engl J Med 2007;357:728.] (Pubitemid 46789893)
25. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72. [Erratum, J Allergy Clin Immunol 2007;120:285.] (Pubitemid 46043379)
26. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005;115:233-42. (Pubitemid 40215084)
27. Litonjua AA, Lasky-Su JA, Schneiter K, et al. ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med 2008;178:688-94.
28. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004;13:1353-9. (Pubitemid 38961642)
29. Himes BE, Hunninghake GM, Baurley JW, et al. Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 2009;84:581-93.
30. Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008;40:161-9. (Pubitemid 351171403)
31. International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
32. Lange C, van Steen K, Andrew T, et al. A family-based association test for repeatedly measured quantitative traits adjusting for unknown environmental and/or polygenic effects. Stat Appl Genet Mol Biol 2004;3:Article17.
33. Liptak T. On the combination of independent tests. Magyar Tudomanyos Akademia Matematikai Kutato Intezetenek Kozlemenyei 1958;3:171-97.
34. Won S, Morris N, Lu Q, Elston RC. Choosing an optimal method to combine P-values. Stat Med 2009;28:1537-53.
35. Stranger BE, Forrest MS, Clark AG, et al. Genome-wide associations of gene expression variation in humans. PLoS Genet 2005;1(6):e78.
36. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007;39:1217-24. (Pubitemid 47482691)
37. Chapman MS, Qu N, Pascoe S, et al. Isolation of differentially expressed sequence tags from steroid-responsive cells using mRNA differential display. Mol Cell Endocrinol 1995;108:R1-R7.
38. Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL. Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 1996;10:967-78. (Pubitemid 26268879)
39. Ho CY, Wong CK, Ko FW, et al. Apoptosis and B-cell lymphoma-2 of peripheral blood T lymphocytes and soluble fas in patients with allergic asthma. Chest 2002;122:1751-8. (Pubitemid 35366092)